Figure 336

![Figure 336: Mediation analysis diagram illustrating the potential pathway through which eicosapentaenoic acid (EPA) may influence inflammatory bowel disease (IBD) risk via circulating metabolites. Direct and indirect effects are quantified using two-step Mendelian randomization, highlighting metabolites that may partially mediate the observed association.]()

> Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." *Metabolites*, 2023. PMID: [37887366](https://pubmed.ncbi.nlm.nih.gov/37887366/)

<figure>
  <img src="" alt="Mediation analysis diagram illustrating the potential pathway through which eicosapentaenoic acid (EPA) may influence inflammatory bowel disease (IBD) risk via circulating metabolites. Direct and indirect effects are quantified using two-step Mendelian randomization, highlighting metabolites that may partially mediate the observed association." />
  <figcaption>Figure 336. Mediation analysis diagram illustrating the potential pathway through which eicosapentaenoic acid (EPA) may influence inflammatory bowel disease (IBD) risk via circulating metabolites. Direct and indirect effects are quantified using two-step Mendelian randomization, highlighting metabolites that may partially mediate the observed association.<br>  Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." <em>Metabolites</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37887366/">37887366</a></figcaption>
</figure>